AVX underwent a dramatic transformation with massive increases in cash (+4418%), assets (+1711%), and equity (+2960%) alongside explosive revenue growth (+3348%), but operating losses more than doubled.
The language changes reveal this appears to be a different company entirely - AgriForce Growing Systems based in Vancouver - suggesting a reverse merger or major corporate restructuring rather than organic growth at AVX. The financial metrics show characteristics of a capital raise or business combination that fundamentally changed the entity's scale and operations.
The company experienced extraordinary growth across all balance sheet items with cash jumping from $490K to $22.1M and total assets expanding from $10.8M to $195M, indicating major capital infusion or acquisition activity. Despite revenue surging 3348% to $2.3M, the company turned unprofitable at the gross margin level and operating losses doubled to $21.7M, while R&D spending was dramatically cut by 91%. The overall picture suggests a transformative corporate event that created a much larger but operationally struggling entity with significant cash resources but deteriorating operational performance.
Cash position surged 4418.7% — strong cash generation or capital raise providing significant financial cushion.
Strong top-line growth of 3348.1% — accelerating demand or successful expansion into new markets.
Equity base grew 2959.5% — retained earnings accumulation or equity issuance strengthening the balance sheet.
Current assets grew 2463% — improving short-term liquidity or inventory/receivables build.
Asset base grew 1711.3% — expansion through organic growth, acquisitions, or capital deployment.
Gross margin compression — rising input costs, pricing pressure, or unfavorable product mix shift.
Operating cash flow fell 174% — earnings quality concerns; investigate working capital changes and non-cash items.
Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.
Net income declined 104% — review whether driven by operations, interest costs, or non-recurring items.
R&D spending cut 91.1% — could signal cost discipline or concerning reduction in innovation investment.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →